 |
Previous Article | Next Article 
Volume 17, Number 21,
Issue of November 1, 1997
pp. 8506-8519
Copyright ©1997 Society for Neuroscience
Neurturin and Glial Cell Line-Derived Neurotrophic Factor
Receptor- (GDNFR- ), Novel Proteins Related to GDNF and GDNFR-
with Specific Cellular Patterns of Expression Suggesting Roles in the
Developing and Adult Nervous System and in Peripheral Organs
Johan Widenfalk1,
Christopher Nosrat1,
Andreas Tomac1, 2,
Heiner Westphal2,
Barry Hoffer3, and
Lars Olson1
1 Department of Neuroscience, Karolinska Institute,
S-171 77 Stockholm, Sweden, 2 National Institute of Child
Health and Human Development, Bethesda, Maryland 20892-2780, and
3 National Institute on Drug Abuse, National Institutes of
Health, Baltimore, Maryland 21224
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
FOOTNOTES
REFERENCES
ABSTRACT
Cloning strategies were used to identify a gene termed glial cell
line-derived neurotrophic factor receptor- (GDNFR- ) related to
GDNFR- . In situ hybridization was then used to map
cellular expression of the GDNF-related trophic factor neurturin (NTN) and GDNFR- mRNA in developing and adult mice, and comparisons with
GDNFR- and RET were made. Neurturin is expressed in postnatal cerebral cortex, striatum, several brainstem areas, and the pineal gland. GDNFR- mRNA was more widely expressed in the developing and
adult CNS, including cerebral cortex, cerebellum, thalamus, zona
incerta, hypothalamus, brainstem, and spinal cord, and in subpopulations of sensory neurons and developing peripheral nerves. NTN
colocalized with RET and GDNFR- in ureteric buds of the developing kidney. The circular muscle layer of the developing intestines, smooth
muscle of the urether, and developing bronchiolae also expressed NTN.
GDNFR- was found in myenteric but not submucosal intestinal
plexuses. In developing salivary glands NTN had an epithelial
expression, whereas GDNFR- was expressed in surrounding tissue.
Neurturin and GDNFR- were present in developing sensory organs. In
the gonads, NTN appeared to be expressed in Sertoli cells and in the
epithelium of the oviduct, whereas GDNFR- was expressed by the germ
cell line. Our findings suggest multiple roles for NTN and GDNFR- in
the developing and adult organism. Although NTN and GDNFR-
expression patterns are sometimes complementary, this is not always the
case, suggesting multiple modi operandi of GDNF and NTN in relation to
RET and the two binding proteins, GDNFR- and GDNFR- .
Key words:
GDNF;
neurturin;
GDNFR- ;
GDNFR- ;
RET;
in
situ hybridization;
CNS;
development;
kidney;
gastrointestinal
tract;
gonads;
kainic acid;
GFR -1;
GFR -2
INTRODUCTION
Glial cell line-derived neurotrophic
factor (GDNF) (Lin et al., 1993 ; Unsicker, 1996 ; Olson, 1997 ) is a
distant member of the TGF- superfamily, which is expressed in many
neuronal and non-neuronal tissues during development and, to a lesser
extent, in the adult animal (Schaar et al., 1993 ; Strömberg et
al., 1993 ; Henderson et al., 1994 ; Hellmich et al., 1996 ; Nosrat et
al., 1996 ; Suvanto et al., 1996 ). GDNF signaling is mediated through a
two-component system consisting of a
glycosyl-phosphatidyl-inositol-linked protein termed GDNF receptor-
(GDNFR- ) (Jing et al., 1996 ; Treanor et al., 1996 ), which binds
GDNF, after which the GDNF-GDNFR- complex binds to and activates
the tyrosine kinase receptor RET (Durbec et al., 1996 ; Trupp et al.,
1996 ). In situ hybridization studies of the three gene
products, GDNF, RET, and GDNFR- , have revealed many examples in
which a given set of cells expresses GDNF mRNA, whereas cells on which
GDNF is assumed to act express both RET and GDNFR- (Nosrat et al.,
1997 ; Trupp et al., 1997 ).
Interestingly, however, there are cases in which the
GDNF-RET/GDNFR- match is not obvious. For instance, GDNFR- mRNA
is present in brain areas such as the developing ventral striatum and
the olfactory tubercle as well as in hippocampus, whereas the
corresponding expressions of RET mRNA are not found (Nosrat et al.,
1997 ). Moreover, there are instances in which RET, but not GDNFR- ,
is found in the brain such as in areas of cerebellum, the olfactory
bulb, and the subthalamic nucleus (Trupp et al., 1997 ). These
observations suggest either that the two receptor components may
function independently of each other and/or that other ligands and/or
receptor components exist. The first alternative may be true for
Schwann cells, which express GDNFR- but not RET (Treanor et al.,
1996 ). In this case, the situation may be analogous to the expression
by Schwann cells of the p75 NGF receptor, but not trkA,
suggesting that Schwann cells produce NGF, which is secreted and binds
to the p75 receptors to be presented to growing nerve fibers.
Similarly, GDNF, also known to be produced by Schwann cells (Trupp et
al., 1997 ), may be presented to nerve fibers bound to GDNFR- in the
cell membrane.
An alternative explanation to apparent mismatches between GDNF and its
receptor components requires the presence of additional gene-related
products. So far, other RET-related tyrosine kinase receptors have not
been identified, but a protein with a high degree of similarity to GDNF
was recently discovered and termed "neurturin" (NTN) (Kotzbauer et
al., 1996 ). The existence of two (and possibly more) proteins in the
GDNF family also suggested that the GDNFR- (Jing et al., 1996 ;
Treanor et al., 1996 )-RET (Durbec et al., 1996 ; Jing et al., 1996 ;
Treanor et al., 1996 ; Trupp et al., 1996 ) dual receptor complex would
not suffice if receptor-specific actions of GDNF and NTN were to be
expected. Therefore, we and others have searched for possible
GDNFR- -related binding proteins. Here we report finding a
GDNFR- -related gene, with ~50% homology to GDNFR- , which we
have termed GDNFR- . While the present paper was in preparation,
three independent studies reported the presence of this same gene,
expressed the protein, and called it "TGF- -related neurotrophic
factor receptor 2" (TrnR2) (Baloh et al., 1997 ), "RETL2"
(Sanicola et al., 1997 ), and "NTNR" (Buj-Bello et al., 1997 ; Klein
et al., 1997 ), respectively. The different names given to this receptor
are reflections of the almost simultaneous and independent discovery of
its existence in different laboratories. Most recently it has been
suggested that GDNFR- should be called GFR -1 and GDNFR- should
be called GFR -2, but there is still no general agreement (GFR
Nomenclature Committee). The term GDNFR- finds some support in the
fact that both GDNF and NTN appear able to bind to and act through
GDNFR- (Baloh et al., 1997 ; Sanicola et al., 1997 ). There is no
previous information about the cellular expression of NTN mRNA and only limited information about the cellular expression of
GDNFR- /TrnR2/RETL2/NTNR- (Klein et al., 1997 ; Sanicola et al.,
1997 ). Therefore, to complement existing studies of the distribution of
the tyrosine kinase receptor RET and of GDNFR- performed by us and
by others (Nosrat et al., 1997 ; Trupp et al., 1997 ), we have also
performed a detailed analysis of cellular expression patterns of
GDNFR- in the present study. We additionally compared the
distribution of NTN and GDNFR- mRNA with the expression of GDNF,
RET, and GDNFR- mRNA in adjacent tissue sections to determine the
neuroanatomical and histological basis for possible interactions
between GDNF and NTN with the three known receptor components.
MATERIALS AND METHODS
Cloning of GDNFR- sequences
EST homology search. A homology search was
performed against the NCBI World Wide Web server dbEST database
(http://www.ncbi.nlm.nih.gov/dbEST/index.html) using the sequences for
the human and rat GDNFR- . Homology was found to W73681, W73633,
R02135, H12981, H05619, T03342, R02249, and HFC1KA111. Highest homology
was found against H12981. The clone was obtained (Genome Systems Inc.) and fully sequenced (1051 bp). Based on this sequence information the
following oligonucleotides were produced for in situ
hybridization: CCCAATCATGCCAGCATAAGAGCCCAGACACGCCTGGTAATT and
CTGGATGGCGTTCCGGAGGCATGGGTTCTCGGTGAAGTC CCTGA.
Screening of EST-tagged filters. pAT112 containing a
partial fragment of the human GDNFR- cDNA was digested with
NotI and SphI that cuts in the MCS flanking
fragment. A fragment of ~300 bp was gel-isolated and used as a
hybridization probe to screen EST high-density gridded filters (Genome
Systems). Twenty-six unique double-positive clones were identified,
sequenced, and compared against the human GDNFR- sequence using a
BLAST search. GS21 (corresponds to GenBank accession number H12981)
again showed the highest homology of all clones sequenced. The
sequences identified by these two approaches were identical to those
recently reported by Baloh et al. (1997) and Buj-Bello et al.
(1997) .
Animals
Embryonic day 17 (E17; n = 2), E19
(n = 2), and E20 (n = 2) and postnatal
day 1 (P1; n = 4), P7 (n = 4), and P14
(n = 4) as well as adult (n = 4) BALB-c
mice (B&K Universal, Sollentuna, Sweden) were used for the in
situ hybridization mapping studies. Adult mice, litters, and
staged pregnant females were kept under standardized light,
temperature, and humidity conditions and given food and water ad
libitum. Adult female 150 gm Sprague Dawley rats were kept under
similar conditions and used for the kainic acid experiments. Postnatal
and adult mice were killed by cervical dislocation; fetuses and adult
rats were killed by decapitation.
In situ hybridization
Serial 14 µm sections were used for in situ
hybridization with oligonucleotide probes for neurturin, GDNF, c-RET,
GDNFR- , and GDNFR- . Two nonoverlapping oligonucleotide probes
complementary to mouse GDNF (50 mer probes from bases 456-505 and
540-589 in the sequence deposited in GenBank, accession number
L15305), an antisense oligonucleotide probe complementary to the base
pairs 547-596 in the extracellular domain of RET, two different
antisense oligonucleotide probes complementary to base pairs 100-149
and 805-851 in GDNFR- (GenBank, accession number U59486), two different neurturin antisense oligonucleotide probes (50 mer probes from bases 679 and 970, GenBank, accession number U78109), and
oligonucleotide probes to the two defined regions of GDNFR- described above were also synthesized (DNA Technologies, Aarhus, Denmark; and Scandinavian Gene Synthesis, Köping, Sweden). The oligonucleotide probes had no significant similarities to other sequences deposited in GenBank, and each pair generated identical in situ hybridization pattern in tissue. A 50 mer random
control probe was used as a negative control (Nosrat and Olson, 1995 ). The in situ hybridization protocol using radiolabeled
oligonucleotides was according to the method of Dagerlind et al. (1992)
(also see Nosrat et al., 1996 ). After development, the slides were
counterstained with cresyl violet or toluidine blue and mounted
(Entellan; Merck, Darmstadt, Germany). Photomicrographs of the sections
were scanned and digitally processed for brightness and contrast.
Microscopically verified artifacts such as dust particles and loosened
tissue fragments were retouched.
Specificity considerations. To ascertain specificity of the
observed hybridization signals, we used two different nonoverlapping probes for each mRNA species except c-RET. In this case we had previously found that one of our probes, directed toward a sequence coding for the extracellular domain of the protein kinase receptor, displays a considerably higher signal-to-noise ratio than a second probe, directed toward a sequence in the intracellular protein kinase
domain. Pairs of probes generated the same hybridization patterns. The
GDNF, RET, and GDNFR- probes have been characterized previously
(Nosrat et al., 1996 , 1997 ). All hybridization was performed under high
stringency conditions. Tissue sections hybridized with the random probe
were processed together with the specific probes.
Positive controls included (1) the use of two nonoverlapping probes for
a given mRNA species, (2) observation of correct labeling patterns in
known areas when possible, and (3) microscopy performed by two
independent experienced observers who agreed on all findings. Negative
controls included (1) the inclusion of a random control (2) the fact
that specific probes failed to label irrelevant structures, and (3) the
different probes functioning as controls for each other, because they
had similar GC contents. The specificity of the in situ
hybridization procedure is dependent on high stringency conditions (in
particular the rinsing temperatures) used and the positive and negative
controls described above. It can nevertheless not be excluded that the
probes also hybridize to unknown but related species of mRNA if such
mRNA species exist that have two 50 mer sequences that are both equal,
or almost equal, to the chosen areas of our probes.
Detection of positive autoradiographic signals was based on
observations of accumulations of silver grains in the emulsion above
specific cells and tissues identified by the staining procedures and
seen in serially sectioned material. Only cells over which accumulations were clearly above the surrounding background level, detectable using dark-field microscopy and a primary magnification of
10×, were regarded as positive. To allow direct comparisons of the
distribution of different species of mRNA, serial sectioning and
labeling of consecutive sections with different probes was used. All
comparisons were thus based on tissues sectioned, hybridized, exposed
to emulsion, and further processed together.
RNA isolation and Northern blots
Total RNA was isolated from different frozen tissues of
6-week-old C57/BL mice. Thirty grams of total RNA were electrophoresed in 1% agarose-formaldehyde gels and blotted onto GeneScreen Plus membranes. Membranes were then hybridized with a
32P-labeled GDNFR- cDNA probe, washed at high stringency
(0.1× SSC and 0.1% SDS, 55°C), and exposed to films (Kodak
BioMax-MS; Eastman Kodak, Rochester, NY).
RESULTS
Neurturin and GDNFR- mRNA expression in developing and
adult mice
The distribution of NTN and GDNFR- mRNA in different
areas of the CNS and selected other tissues is summarized in Table
1. Table 2
compares selected observations described in Table 1 with what is known
about the presence of GDNF, RET, and GDNFR- mRNA in tissues using
in situ hybridization. In the following, we shall discuss
positive and negative findings from in situ hybridization of
NTN and GDNFR- . We will confine our descriptions of NTN and GDNFR- hybridization patterns in the CNS to gray matter and
expression patterns that appear to be neuronal. Methodological
constraints associated with nonspecific labeling of white matter tracts
for certain oligonucleotide probes limit the ability to study
expression in glial elements uniquivocally.
The olfactory bulb
Neurturin mRNA was not found in the olfactory bulb. GDNFR-
mRNA, however, was seen in the olfactory bulb, notably in the mitral
cell layer and the internal plexiform layer.
Cortex cerebri, the hippocampal formation, and septum
Neither of our two oligonucleotide probes detected any NTN mRNA in
these areas of the prenatal mouse CNS. Two weeks after birth, strong
NTN mRNA expression was found in cingulum (Fig. 1C), subiculum, and the
entorhinal cortex. A thin layer of cells in basal cortex, close to
corpus callosum was also NTN mRNA-positive, although at a somewhat
weaker level. Labeled cells in subiculum were large nonpyramidal
neurons. Robust NTN mRNA signals were not seen in neurons of the adult
mouse cortex or hippocampal formation.
Fig. 1.
NTN mRNA hybridization signals in the mouse brain
during P7 and P14. Expression of NTN mRNA 1 week after birth is seen,
e.g., in the central gray (A), corpus pineale
(P) (A) and parts of the entorhinal cortex (B, arrowhead). Two weeks after birth
there is labeling of the caudate putamen (CP) and
cingulum (Cg) (C). The caudate
putamen appears somewhat diffusely labeled with the NTN probe, and one
observes an increasing gradient of labeling laterally. Scale bars:
A, B (shown in A), 1 mm;
C, 1 mm.
[View Larger Version of this Image (174K GIF file)]
GDNFR- mRNA hybridization was found in cortex cerebri from birth to
adulthood, with the strongest signals observed at P14. The cortical
GDNFR- mRNA was found mainly in two layers corresponding to layers 3 and 4 and parts of layers 5 and 6 (Fig.
2). Frontal, parietal, and occipital
cortex contained labeled cells laterally down through the temporal
association cortex for the outer layer of labeled cells and down to
perirhinal cortex for the inner layer of labeled cells. Medial cortex
had the most distinct expression.
Fig. 2.
GDNFR- mRNA signal in adult cortex and
lateral septum (A, dark-field view). Higher
magnification (B, bright-field view) reveals signal in
parts of the frontal cortex in layers 3 and 4. Scale bars:
A, 1 mm; B, 50 µm.
[View Larger Version of this Image (88K GIF file)]
RET mRNA was seen in P7 medial and parietal cortex, and GDNFR- mRNA
was seen only in medial cortex (Fig.
3A,C). The GDNFR- signals
at P7 were mainly observed in cortical layers, which appeared to be
intercalated with those of RET mRNA expression (Fig.
3A,E).
Fig. 3.
Comparison between prominent RET, GDNFR- , and
GDNFR- mRNA expression in 1-week-old mouse brain, dark-field view.
All three genes show strong expression in zona incerta
(ZI) and the reticular thalamic nucleus
(Rt) (A, C, E). In the dentate gyrus, a
positive signal is seen for GDNFR- and GDNFR- (C,
E), but not for RET. Dopamine neurons of substantia nigra
(SN) and the ventral tegmental area have a
distinct expression pattern of RET and GDNFR- (B, D),
whereas GDNFR- is absent or very weakly expressed
(F). Cortex cerebri represents another
area where the signal distribution differs markedly: GDNFR- labels
two layers in cingulum and frontal and parietal cortices
(E), GDNFR- labels only medial cortex
(C), and RET labels almost the same areas as
GDNFR- , but slightly weaker and in two different cortical layers
(A). GDNFR- appears diffusely in many areas in
the brainstem, such as the superior colliculus
(F). Distinct signals for GDNFR- , but
not for RET and GDNFR- , are seen in the medial habenula
(MHb), corpus pineale (P), and
cornu ammonis caudally. The trigeminal ganglion shows signal for
GDNFR- , GDNFR- , and RET, although strongest for the latter. Scale
bars: A, C, E (shown in E), 100 µm;
B, D, F (shown in F), 100 µm.
[View Larger Version of this Image (190K GIF file)]
Neuronal NTN mRNA expression was below our detection limit in the
hippocampal formation. GDNFR- mRNA was found postnatally to be
weakly expressed in stratum oriens of CA1 and CA2 of the posterior
hippocampus and relatively distinct in the dentate gyrus (Figs.
3E, 4E, 5A,
6B). In septum we found NTN mRNA-positive neurons in
the lateral parts at P7 and P14. GDNFR- mRNA signals were found in
lateral septum from birth and in all postnatal stages (Figs.
2A, 5A).
Fig. 4.
Dark-field photomicrographs depicting distribution
of the different GDNF receptor mRNA species in adjacent sections of
adult substantia nigra. Both RET and GDNFR- mRNA give rise to robust hybridization signals in the dopamine neurons of substantia nigra and
the ventral tegmental area (A-D),
whereas GDNFR- is only weakly expressed in the ventral tegmental
area (F). All three probes are positive in
the supramammillary nucleus (A-F). The dentate gyrus is positive for GDNFR- and GDNFR- but not for RET
mRNA (A, C, E). Other areas of GDNFR- mRNA signal
include the peripeduncular nucleus, superior colliculus, and two layers in cortex. Note that in contrast to GDNFR- , RET and GDNFR- are not detectable in cortex. Scale bars: B, D, F (shown in
F), 1 mm; A, C, E (shown in
E), 2 mm.
[View Larger Version of this Image (187K GIF file)]
Fig. 5.
High-magnification bright-field photomicrographs
of some of the most prominent neuronal GDNFR- hybridization signals
in the brain. A, The lateral dentate gyrus in a
1-week-old mouse shows distinct hybridization signal. B,
In cingulum at the same stage several layers are positively labeled.
C, A distinct signal for GDNFR- mRNA is found in the
adult zona incerta. D, The lateral septum in the
2-week-old mouse also shows strong labeling. Scale bars: A, B,
C (shown in A), 50 µm; D, 50 µm.
[View Larger Version of this Image (132K GIF file)]
Fig. 6.
Dark-field images depicting GDNFR- and
GDNFR- mRNA expression in neonatal mouse CNS. Prominent
hybridization of the GDNFR- probe is seen in zona incerta, dentate
gyrus, the trigeminal ganglia, and the superior and inferior colliculus
(B). No robust GDNFR- signal is observable in
the substantia nigra area (SN) in contrast to
GDNFR- (A). Cerebellum is positive for
GDNFR- , especially in the Purkinje cell layer
(C). Cb, Cerebellum;
DG, dentate gyrus; IC, inferior
colliculus; fn, facial nucleus; m,
mesencephalic flexure; Mo5, trigeminal motor nucleus;
SC, superior colliculus; TG, trigeminal
ganglion; ZI, zona incerta. Scale bar (shown in C): A, B, 250 µm; C, 125 µm.
[View Larger Version of this Image (97K GIF file)]
Cerebellum
Neurturin mRNA was not observed in cerebellar neurons. GDNFR-
mRNA hybridization was present in the developing cerebellum from E19
and onward in the Purkinje cell layer (Fig. 6C). This signal
appeared to peak around P7 and was still present in the adult.
Dopamine systems and the basal ganglia
Neurturin mRNA was expressed in the postnatal striatum (Fig.
1C,D). Modest signals were seen at P7, and stronger signals
were seen at P14. It appeared as if the expression was neuronal, and at
P14 a mediolateral gradient of increasing signal strength was noted. We
were unable to see a patch or matrix pattern of NTN mRNA distribution
in striatum. GDNFR- mRNA was not detected in striatum.
Figures 4 and 6, A and
B, compare the expression of RET, GDNFR- and GDNFR-
receptor components in the substantia nigra area of mesencephalon of
adult and newborn mice. Although RET and GDNFR- mRNA are both
clearly present in the A9 and A10 dopamine neurons, as demonstrated
previously (Nosrat et al., 1997 ), consecutive sections hybridized for
GDNFR- revealed that almost no dopamine neurons express this
molecule. GDNFR- mRNA, however, was detected from P0 and onward into
adulthood in the substantia nigra area. It was also diffusely
distributed in VTA from birth onward. Areas of the interpeduncular
nucleus, the adult supramammillary nucleus, and the peripeduncular
nucleus were all GDNFR- -positive (Fig. 4E,F). GDNFR- was also expressed in the
adult supramammillary nucleus.
Thalamus
NTN was not detected. GDNFR- mRNA was detected in thalamic
areas during prenatal development. In the adult thalamus we found labeling in the reticular thalamic nucleus (Fig. 3E). This
nucleus was also GDNFR- mRNA-positive (Fig. 6A);
GDNFR- (Fig. 5C) and RET
hybridization both revealed distinct signaling in zona incerta at all
postnatal stages investigated (Figs 3A,C,E,
6B). GDNFR- and GDNFR- were also positive in
the zona incerta area of E17 and E19 fetuses.
Hypothalamus
NTN mRNA was not seen. There were multiple GDNFR- mRNA-positive
areas in hypothalamus at all stages investigated. One area with strong
signals was the ventromedial hypothalamic nuclear complex, particularly
prominent at P14.
Habenula and pineal gland
A weak GDNFR- signal was found in the postnatal habenula area.
In comparison, GDNFR- mRNA was strongly expressed in the medial
habenular nucleus, whereas RET mRNA was not prominent (Fig. 3A,C,E). Interestingly, the developing P7 pineal gland was
found to express NTN mRNA at a rather high level (Fig.
1A).
Brainstem
Neurturin mRNA signals begin to appear in this area around birth.
Nuclei in the periaqueductal gray and certain other brainstem areas
showed weak signals (Fig. 1A,B). Neurturin mRNA
hybridization was found in mesencephalon at P7 and P14. Positive cells
were also found in the interpeduncular nucleus at P14. GDNFR- mRNA expression was prominent in the trigeminal motor nucleus and the facial
nucleus at P0 (Fig.
6A). GDNFR- mRNA
signals were found distributed throughout large areas of the E17-E20
brainstem. Postnatally, GDNFR- continued to be widely expressed in
many brainstem areas (Fig. 6B), including the
colliculi and the interpeduncular, peripeduncular, cochlear, and
tegmental nuclei.
Spinal cord
In contrast to GDNF mRNA, which has been reported to be expressed
in the embryonic spinal cord, we did not observe NTN mRNA expression at
any stage investigated. GDNFR- , on the other hand, showed an
expression pattern reminiscent of that of GDNFR- in the spinal cord
(Fig. 7C,D). At P7 GDNFR-
mRNA hybridization was found in gray matter labeling most neural cells,
including -motor neurons (Fig. 7C,D). GDNFR- at the
same stage was strongly positive in motor neurons and more weakly
expressed in other neuronal elements (Fig. 7C). GDNFR- ,
in contrast to GDNFR- , was also expressed in the adult spinal
cord.
Fig. 7.
GDNFR- mRNA hybridization in developing spinal
cord. Hybridization is observed in most neurons of the spinal cord
during development (bright-field, A; and dark-field,
B, D) and in a subset of neurons in the dorsal root
ganglia (dark-field image, D). The positive labeling is
continuous from medulla oblongata and downward at birth as shown in
sagittal section (B). One week later (P7) GDNFR- mRNA signals are still present throughout gray matter, labeling most neurons, including -motor neurons (A,
D). Compared with GDNFR- (C),
which has a similar expression pattern, the most striking difference is
the relatively weak expression of GDNFR- mRNA in -motor neurons
(compare arrows in C, D).
CC, Canalis centralis. C1, First cervical
vertebrae. Scale bars: A, 50 µm; B, 125 µm; C, D (shown in C), 250 µm.
[View Larger Version of this Image (129K GIF file)]
Peripheral nervous system
Neurturin mRNA was not found in any ganglia investigated.
GDNFR- mRNA, on the other hand, was strongly expressed at all stages studied in a subpopulation of neurons of both dorsal root ganglia (small- to medium-sized neurons; Fig. 7A) and the trigeminal
ganglion (medium to large neurons; Fig. 6B). The
pattern of GDNFR- expression in dorsal root ganglia appeared not to
overlap that of GDNFR- (Fig. 6A), whereas RET mRNA
was expressed in the vast majority of ganglion perikarya. Postnatal
superior cervical ganglia also had strong GDNFR- -positive neurons at
all investigated stages. In peripheral nerves we did not see NTN mRNA
expression during development. Neonatal peripheral nerves were strongly
positive for GDNFR- mRNA (Fig.
8E).
Fig. 8.
Examples of NTN and GDNFR- mRNA hybridization
in the P0 trigeminal system (A--E) and of
GDNFR- mRNA in the E20 lung. In the olfactory epithelium NTN and
GDNFR- mRNA appear in complementary patterns (dark-field, A,
C). NTN mRNA is found in the olfactory epithelium, especially
in Bowman's glands (C, arrows), and GDNFR- is found
in lamina propria of the olfactory mucosa, a tissue containing abundant
nerves and vessels. Vibrissae are positive for GDNFR- (bright-field
image, B; dark-field image, E), as are
peripheral nerves exemplified by nervus maxillaris (E,
arrowheads). D, A subpopulation of neurons in
the trigeminal ganglion are positively labeled for GDNFR- mRNA. In
the developing lung GDNFR- is found in the stromal tissue
(dark-field, F). Scale bars: A,
500 µm; B, 50 µm; C, 500 µm;
D, 50 µm; E, 250 µm;
F, 200 µm.
[View Larger Version of this Image (221K GIF file)]
Kidney and ureter
Figure 9 shows consecutive sections
of the E19 kidney hybridized for all five known genes in the GDNF
families of factors and receptors. Interestingly, NTN mRNA is found in
the developing buds of the metanephric ducts (Fig. 9B).
GDNFR- was not found in the mesenchyme or in the developing
epithelial components. Weak GDNFR- signals were associated with
central pelvic regions of the developing kidney (Fig. 9E).
The smooth muscle layer of the E20 urether expressed a strong NTN mRNA
signal.
Fig. 9.
E20 salivary glands and adult testis. Neurturin
and GDNFR- mRNA show a complementary expression pattern in both
organs. The developing tubules in the salivary glands are labeled by
NTN hybridization (B), whereas GDNFR- mRNA is
represented in the stroma surrounding the epithelial structures
(A). In testis a very strong neurturin mRNA
signal is seen in the periphery of some of the seminiferous tubules,
suggesting localization to the Sertoli cells (C,
dark-field view; D, bright-field view). GDNFR- is
also expressed in some of the tubules, but at levels indicating
localization to the germ cells (E, F). Scale
bars: A, B, 200 µm; C-F, 100 µm.
[View Larger Version of this Image (192K GIF file)]
Gastrointestinal tract
During development, NTN mRNA was found exclusively in the circular
layer of the external smooth muscle layer both prenatally and
postnatally but not in the adult. During the same developmental period,
GDNFR- was expressed in the myenteric plexus of Auerbach but not in
the submucous plexus of Meissner. These patterns of expression
therefore differ from those of GDNF mRNA, which is present in both the
circular and longitudinal outer smooth muscle layers, and of RET and
GDNFR- mRNA, which are both present in the myenteric as well as the
submucous plexuses.
Exocrine glands
Interestingly, NTN and GDNFR- mRNA were both present in the
developing salivary glands (Fig.
10A,B). Although NTN
appeared to be present in the epithelial portions of the glands,
GDNFR- had a more peripheral and therefore complementary expression
in the interstices of the glandular tissues. These expression patterns were seen in the submandibular gland and the parotid gland.
Additionally, such complementary labeling patterns were seen in the
lingual glands of von Ebner and other small salivary glands of the oral cavity. Neurturin mRNA expression was also found in the Harderian gland
of the orbit at P0 and P7. GDNFR- was not seen at P7 in the
Harderian gland.
Fig. 10.
Dark-field photomicrographs showing the mRNA
distribution of all known GDNF family members in the developing kidney
at embryonal day 19 (A-E). NTN mRNA is expressed
in the developing epithelial buds. GDNF mRNA, in contrast, is localized
in peripheral mesenchyme. GDNFR- and RET show similar patterns of
probe labeling in the peripheral epithelial buds, whereas GDNFR-
could not be detected in the periphery. Weak GDNFR- as well as weak
NTN hybridization signals were found in pelvic regions of the
developing kidney. Scale bar (shown in A), 500 µm.
[View Larger Version of this Image (69K GIF file)]
Sense organs
In the developing retina, weak expression of NTN mRNA was found in
the pigment cell layer at P7. GDNFR- mRNA was found in the retina at
P0 and P7 located in different cell types. In the inner ear there were
clear-cut NTN mRNA signals from E17 to E20 and a weak signal at P0.
GDNFR- was weakly expressed at E17 and E19.
In the olfactory mucosa, NTN mRNA was found in the developing glands of
Bowman, whereas robust GDNFR- mRNA expression was found immediately
below the olfactory epithelium (Fig. 8A,C). In
vibrissae, GDNFR- as well as NTN mRNA was expressed during development (Fig. 8B,E). GDNFR- mRNA was also
present around lower parts of hair follicles during development.
Striatal musculature
A weak NTN mRNA signal was found in the E17 myocardium. Neurturin
continued to be expressed at a low level throughout prenatal development in heart musculature. The expression was somewhat stronger
during the first two postnatal weeks and included the auricle.
GDNFR- mRNA was not seen in the developing heart except for a low
signal intensity in vessel walls. Neurturin mRNA was not observed in
skeletal muscle.
Lung
A weak to moderate NTN mRNA signal was noted in the E17-E20 lung.
GDNFR- mRNA was present at higher levels from E17 to E20 and at low
levels at P0. Although NTN mRNA was located in the walls of the
bronchiolar system, GDNFR- mRNA was expressed in the surrounding
developing lung parenchyma.
Adrenal gland
Neurturin mRNA was not noted at E20. GDNFR- mRNA was not
found in the developing adrenal at E17 or E20. At P7, however, there was a GDNFR- signal in the developing zona glomerulosa.
Gallbladder
Neurturin and GDNFR- mRNA appeared to have a
complementary distribution in the perinatal gallbladder. Thus, NTN mRNA
was found in the epithelium at moderate levels at E20, whereas
GDNFR- mRNA was found under the epithelium at P7 and P14.
Pituitary gland
NTN mRNA was seen in the P0 pituitary gland (Fig.
1A). GDNFR- mRNA was not noted at E17, E19, or
P0.
Gonads
A relatively strong GDNFR- signal was found in the E19 gonads.
Interestingly, the adult testis displayed a strong NTN mRNA signal
(Fig. 10C,D), which appeared confined to the Sertoli cells, whereas the germ cell line displayed a strong GDNFR- signal in a
mosaic of tubuli seminiferi contorti (Fig.
10E,F). Neurturin mRNA was also strongly
expressed in the oviduct.
Teeth
Both NTN and GDNFR- mRNA signals were detected in the
developing teeth.
Thymus
A weak GDNFR- signal was noted in the P0 thymus.
Northern blots
Northern analysis was used to confirm hybridization of our probe
to specific mRNA species. As can be seen in Figure
11, single bands of the appropriate
size were seen in lung and brain tissue from 6-week-old mice, in
accordance with the in situ hybridization findings in these
tissues. Similarly, the lack of signal in kidney is in accordance with
the lack of in situ hybridization in this tissue. The lack
of a positive band in intestine in all probability reflects the low
sensitivity of this method compared with in situ hybridization, which found a signal restricted to only one ganglionic plexus.
Fig. 11.
Northern blot analysis of GDNFR- levels in
postnatal week 6 mouse tissues. Total RNA from indicated tissues (30 gm/slot) is shown. A 1 kb 32P-labeled GDNFR- cDNA probe
was used for hybridization. Note single bands.
[View Larger Version of this Image (32K GIF file)]
DISCUSSION
To understand neurotrophic signaling and to delineate the roles of
neurotrophic factors and their receptors in the organism, it is
imperative to determine precisely not only which tissues but which
specific cells express the factors and receptors at hand. The discovery
of neurturin, a protein with neurotrophic properties (Kotzbauer et al.,
1996 ) and 42% amino acid homology to GDNF (Lin et al., 1993 ; Unsicker,
1996 ) prompted this first in situ hybridization study of NTN
mRNA expression patterns to complement the patterns of expression of
GDNF as described by us and others (Strömberg et al., 1993 ;
Hellmich et al., 1996 ; Nosrat et al., 1996 ; Suvanto et al., 1996 ).
Although further members of the GDNF family of trophic factors, as well
as further members of the dual component receptor families, may well be
discovered, the five gene products presently known allow for a series
of different possible combinations of receptor components and trophic
factor exposure. Theoretically, the three known receptor components
could be present in cells in seven different combinations. To provide a
histological substrate for these possibilities, we have used
consecutive sections to localize by radioactive in situ
hybridization mRNA generated by all five known genes in the GDNF family
of factors and the corresponding receptors. Interestingly, several of
the theoretical combinations of receptors noted above appear to be
substantiated by the experimental findings. Thus dopamine neurons and
-motor neurons have RET and GDNFR- , similarly, ganglion cells
have RET and GDNFR- or GDNFR- , possibly all three receptors. In
striatum there appear to be cells that express GDNFR- but not RET.
Similarly, Schwann cells appear to express GDNFR- and GDNFR- but
not RET. Our findings, therefore, permit a series of speculations as to
the functions of the novel proteins NTN and GDNFR- in the CNS and in
the peripheral nervous system, as well as in peripheral organs.
Many unique patterns of expression of NTN mRNA were found both within
and outside the CNS, suggesting that NTN has many roles in the
developing and adult organism different from those of GDNF. In the
cerebral cortex, for instance, NTN mRNA is expressed postnatally in
cingulum, subiculum, and areas of entorhinal cortex. Interestingly, GDNFR- mRNA was expressed in cortical layers that appeared
intercalated with those of RET mRNA expression. Although NTN levels
were not detected in the adult cortices, GDNFR- mRNA continued to be
expressed in the adult mouse, suggesting that the GDNFR- ligand in
adult mouse cortex might not be NTN. Moreover, GDNFR- , but not NTN, mRNA was found in the developing and adult cerebellum, again suggesting that GDNFR- might not function together with NTN in this system.
Neurturin, like GDNF (Strömberg et al., 1993 ), is expressed in
the postnatal developing striatum. We did not find GDNFR- mRNA in
this area; neither was there any expression of RET mRNA, whereas
ventral striatum does express moderate levels of GDNFR- (Nosrat et
al., 1997 ). Taking known receptors into account, it therefore appears
that NTN could not exert trophic actions within striatum but, rather,
could be a target-derived trophic factor for a striatal input system.
The mesencephalic dopamine neurons projecting to striatum express RET
and GDNFR- but not GDNFR- mRNA. Hence, NTN could influence these
neurons via their RET-GDNFR- combination. It is, however, also
possible that NTN could have trophic roles for the corticostriatal
input.
In general, GDNFR- is much more widely expressed in brain areas,
both temporally and spatially, than NTN mRNA. For instance, signals in
several areas in thalamus and hypothalamus, including very prominent
GDNFR- mRNA expression in zona incerta, were detected. Together
these observations suggest that GDNFR- subserves roles other than
mediating NTN effects in many areas of the CNS. This observation also
holds true for the spinal cord, in which GDNFR- mRNA expression was
seen in most neural cells of gray matter during development, whereas we
did not detect NTN mRNA. Although GDNFR- levels decreased below the
detection level in adult mice, GDNFR- mRNA expression remained.
In sensory ganglia, distinct populations of neurons expressed
GDNFR- . Our results suggest that populations of dorsal root ganglia
cells expressing GDNFR- and - are mainly nonoverlapping, and that
both the GDNFR- - and GDNFR- -expressing cells may express RET.
However, a more detailed analysis of ganglia is needed to determine
these relationships and the possible existence of cells coexpressing
both binding proteins. It is interesting to note that peripheral nerves
are strongly positive for GDNFR- mRNA during development, suggesting
that Schwann cells, known to produce GDNF (Hammarberg et al., 1996 ),
express both binding proteins but not RET.
Several observations regarding the role of NTN and GDNFR- in
peripheral organs were also made. The kidneys were of great interest,
because both GDNF and RET knock-outs manifest renal agenesis or severe
malformations (Schuchardt et al., 1994; Moore et al., 1996 ; Pichel et
al., 1996 ; Sanchez et al., 1996 ). Interestingly, NTN mRNA was
colocalized with RET and GDNFR- mRNA in the developing buds of the
metanephric kidney, and these buds are embedded in the peripheral
mesenchyme, which is strongly GDNF mRNA-positive. GDNFR- was not
present in these outer parts of the developing kidney, suggesting that
there is both a mesenchymal-epithelial interaction between GDNF in the
mesenchyme and the receptor components RET and GDNFR- in the
epithelial buds, as well as a local autocrine or paracrine effect of
NTN, acting via the same set of receptors within the epithelial
buds.
We also found interesting patterns of expression of NTN in smooth
muscles. Thus, the prenatal developing urether expressed strong NTN
mRNA signals in its smooth muscle layers. Similarly, NTN mRNA was
expressed in the walls of the bronchiolar tree of the developing lungs,
presumably in the smooth muscle cells. In the gastrointestinal tract we
have previously demonstrated that GDNF mRNA is expressed by both the
circular and the longitudinal layers of the outer muscle layer, whereas
RET and GDNFR- are both expressed by the myenteric plexus of
Auerbach and the submucous plexus of Meissner. We now show that NTN
mRNA is expressed exclusively in the circular layer of the external
smooth muscle layer both prenatally and postnatally. Moreover,
GDNFR- mRNA is expressed in the myenteric but not the submucosal
plexus of the intestinal wall. These observations may help explain how
different sets of nerve fibers may innervate the circular versus the
longitudinal muscle layers of the gastrointestinal tract and how the
two neuronal plexuses of the intestines may be differentially
influenced by trophic factors.
The striated musculature of the developing myocardium expressed a low
level of NTN mRNA prenatally, and somewhat stronger expression was seen
during the first 2 postnatal weeks in the myocardium, including
musculature of the auricles. The presence of NTN mRNA in heart striated
musculature may be related to the developing innervation of the heart
and sets this type of striated musculature apart from skeletal striated
musculature, in which NTN mRNA was not found at any stage.
Members of the GDNF families of factors and receptors are important in
sensory systems. In this study we found NTN mRNA to be expressed in the
pigment cell layer of the 1-week-old retina, and GDNFR- mRNA was
found in other cell types of the retina. Both NTN and GDNFR-
expression patterns were also found in the developing inner ear and in
the olfactory mucosa. NTN mRNA was expressed in the developing glands
of Bowmann, whereas GDNFR- was expressed in the submucosa. In the
vibrissae, a prominent and important sensory organ in rodents, both NTN
and GDNFR- mRNA was strongly expressed during development.
Salivary glands represent another interesting example of a
complementary pattern of expression of NTN and GDNFR- mRNA. During development NTN appears to be produced by the epithelial portions of
the glands, whereas GDNFR- appears to be present in the
surroundings. The degree of resolution of the radioactive in
situ hybridization method does not permit us to determine whether
the GDNFR- expression is localized to the myoepithelial cells and/or
interstitial tissue outside of the basal membranes of the glands. Not
only major salivary glands but also small salivary glands of the oral
cavity, such as the glands of von Ebner, displayed this complementary
pattern of mRNA expression.
In developing teeth NTN and GDNFR- mRNA were both expressed.
The complex development of the teeth and the changing pattern of
expression of these two genes will be dealt with elsewhere.
Finally, we have found a very interesting pattern of expression of NTN
and GDNFR- in the gonads and the female genital system. Thus it
appears as if NTN mRNA is expressed by the Sertoli cells, whereas the
germ cell line expresses the GDNFR- receptor. Because NTN mRNA was
also found to be expressed by the epithelium of the oviduct, it is
conceivable that sperm may be influenced first by NTN from the Sertoli
cells and, after reaching the female genital tract, by NTN produced by
the oviduct.
Although only described briefly in the present study, we found that the
immune system and the endocrine system also show patterns of expression
of the GDNF families of factors and receptors. Thus both NTN and
GDNFR- have been noted in the developing pituitary gland.
Strikingly, the 1-week-old pineal gland was found to express NTN mRNA
at a rather high level. We have previously demonstrated that the pineal
gland also expresses GDNF mRNA (Ebendal et al., 1995 ).
In conclusion, the complex and widespread patterns of expression of NTN
and GDNFR- mRNA and the relation of these expression patterns to
those of GDNF, RET, and GDNFR- suggest that the roles of the GDNF
family of proteins and its receptor components are many fold in both
the developing and adult organism, and both within and outside the
nervous system. These relationships may be analogous to those noted for
the nerve growth factor families of trophic proteins and receptors, in
which it is now realized that the neurotrophins exert a plethora of
functions in the organism, including roles in the immune system, the
endocrine system, and the reproductive system. Germ line as well as
somatic mutations of members of the GDNF families of factors and
receptors are known (Mulligan et al., 1993 ; Edery et al., 1994 ; Romeo
et al., 1994 ; Angrist et al., 1996 ; Ivanchuk et al., 1996 ). Both loss
of function and gain of function mutations of RET have been described.
It is not unlikely that additional human mutations of one or several of
the five known gene products may exist in which the manifestations may
be explained by their expression in the organism as described here.
FOOTNOTES
Received June 20, 1997; revised Aug. 18, 1997; accepted Aug. 25, 1997.
This work was supported by Swedish Medical Research Council Grant
14X-03185, AMF, AFA, Petrus och Augusta Hedlunds Stiftelse, and the
United States Public Health Service. We thank Eva Lindqvist, Susanne
Almström, Karin Lundströmer, and Ida Engqvist.
Correspondence should be addressed to Lars Olson, Department of
Neuroscience, Karolinska Institutet, S-171 77 Stockholm, Sweden.
REFERENCES
-
Angrist M,
Bolk S,
Halushka M,
Lapchak P,
Chakravarti A
(1996)
Germline mutations in glial cell line-derived neurotrophic factor (GDNF) and RET in a Hirschsprung disease patient.
Nat Genet
14:341-344[Web of Science][Medline].
-
Baloh R,
Tansey M,
Golden J,
Creedon D,
Heuckeroth R,
Keck C,
Zimonjic D,
Popescu N,
Johnson Jr E,
Milbrandt J
(1997)
TrnR2, a novel receptor that mediates neurturin and GDNF signaling through Ret.
Neuron
18:793-802[Web of Science][Medline].
-
Buj-Bello A,
Adu J,
Piñón L,
Horton A,
Thompson J,
Rosenthal A,
Chinchetru M,
Buchman V,
Davies A
(1997)
Neurturin responsiveness requires a GPI-linked receptor and the Ret receptor tyrosine kinase.
Nature
387:721-724[Medline].
-
Dagerlind Å,
Friberg K,
Bean A,
Hökfelt T
(1992)
Sensitive mRNA detection using unfixed tissue: combined radioactive and non-radioactive in situ hybridization histochemistry.
Histochemistry
98:39-49[Web of Science][Medline].
-
Durbec P,
Marcos-Gutierrez C,
Kilkenny C,
Grigoriou M,
Suvanto P,
Wartiovaara K,
Smith D,
Ponder B,
Constantini F,
Saarma M,
Sariola H,
Pachnis V
(1996)
Glial cell line-derived neurotrophic factor signalling through the Ret receptor tyrosine kinase.
Nature
381:789-792[Medline].
-
Ebendal T,
Tomac A,
Hoffer B,
Olson L
(1995)
Glial cell line-derived neurotrophic factor (GDNF) stimulates fibre formation and survival in cultured neurons from peripheral autonomic ganglia.
J Neurosci Res
40:276-284[Web of Science][Medline].
-
Edery P,
Lyonnet S,
Mulligan L,
Pelet A,
Dow E,
Abel L,
Holder S,
Nihoul-Fékété C,
Ponder B,
Munnich A
(1994)
Mutations of the RET proto-oncogene in Hirschsprung's disease.
Nature
367:378-380[Medline].
-
GFR-
Nomenclature Committee
(1997)
Nomenclature of GPI-linked receptors for the GDNF ligand family.
Neuron
19:485[Web of Science][Medline]. -
Hammarberg H,
Piehl F,
Cullheim S,
Fjell J,
Hökfelt T,
Fried K
(1996)
GDNF mRNA in Schwann cells and DRG satellite cells after chronic sciatic nerve injury.
NeuroReport
7:857-860[Web of Science][Medline].
-
Hellmich H,
Kos L,
Cho E,
Mahou K,
Zimmer A
(1996)
Embryonic expression of glial cell-line derived neurotrophic factor (GDNF) suggests multiple developmental roles in neural differentiation and epithelial-mesenchymal interactions.
Mech Dev
54:95-105[Web of Science][Medline].
-
Henderson C,
Phillips H,
Pollick R,
Avies A,
Lemeulle C,
Armanini M,
Simmons L,
Moffet B,
Vandlen R
(1994)
GDNF: a potent survival factor for motoneurons present in peripheral nerve and muscle.
Science
266:1062-1064[Abstract/Free Full Text].
-
Ivanchuk S,
Myers S,
Eng C,
Mulligan L
(1996)
De novo mutation of GDNF, ligand for the RET/GDNFR-alpha receptor complex, in Hirschsprung disease.
Hum Mol Genet
5:2023-2026[Abstract/Free Full Text].
-
Jing S,
Wen D,
Yu Y,
Holst P,
Luo Y,
Fang M,
Tamir R,
Antonio L,
Hu Z,
Cupples R,
Louis J,
Hu S,
Altrock B,
Fox G
(1996)
GDNF-induced activation of the ret protein tyrosine kinase is mediated by GDNFR-alpha, a novel receptor for GDNF.
Cell
85:1113-1124[Web of Science][Medline].
-
Klein R,
Sherman D,
Ho W,
Stone D,
Bennett G,
Moffat B,
Vandlen R,
Simmons L,
Gu Q,
Hongo J,
Devaux B,
Poulsen K,
Armanini M,
Nozaki C,
Asai N,
Goddard A,
Phillips H,
Henderson C,
Takahashi M,
Rosenthal A
(1997)
A GPI-linked protein that interacts with Ret to form a candidate neurturin receptor.
Nature
387:717-721[Medline].
-
Kotzbauer P,
Lampe P,
Heuckeroth R,
Golden J,
Creedon D,
Johnson Jr E,
Milbrandt J
(1996)
Neurturin, a relative of glial-cell-line-derived neurotrophic factor.
Nature
384:467-470[Medline].
-
Lin L-F,
Doherty D,
Lile J,
Bektesh S,
Collins F
(1993)
GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons.
Science
260:1130-1132[Abstract/Free Full Text].
-
Moore MW,
Klein RD,
Farinas I,
Sauer H,
Armanini M,
Phillips H,
Reichardt LF,
Ryan AM,
Carvermoore K,
Rosenthal A
(1996)
Renal and neuronal abnormalities in mice lacking GDNF.
Nature
382:76-79[Medline].
-
Mulligan L,
Kwok J,
Healey C,
Elsdn M,
Eng C,
Gardner E,
Love D,
Mole S,
Moore J,
Papi L,
Ponder M,
Telenius H,
Tunnacliffe A,
Ponder B
(1993)
Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A.
Nature
363:458-460[Medline].
-
Nosrat C,
Olson L
(1995)
Brain-derived neurotrophic factor mRNA is expressed in the developing taste bud-bearing tongue papillae of rat.
J Comp Neurol
360:698-704[Web of Science][Medline].
-
Nosrat C,
Tomac A,
Lindqvist E,
Lindskog S,
Humpel C,
Ebendal T,
Strömberg I,
Hoffer B,
Olson L
(1996)
Cellular expression of GDNF mRNA predicts multiple functions in and outside the nervous system.
Cell Tissue Res
286:191-207[Web of Science][Medline].
-
Nosrat C,
Tomac A,
Hoffer B,
Olson L
(1997)
Cellular and developmental patterns of expression of Ret and GDNFR-
mRNA.
Exp Brain Res
115:410-422[Web of Science][Medline]. -
Olson L
(1997)
The coming of age of the GDNF family and its receptors: gene delivery in a rat Parkinson model may have clinical implications.
Trends Neurosci
20:277-279[Web of Science][Medline].
-
Pichel JG,
Shen LY,
Sheng HZ,
Granholm AC,
Drago J,
Grinberg A,
Lee EJ,
Huang SP,
Saarma M,
Hoffer BJ,
Sariola H,
Westphal H
(1996)
Defects in enteric innervation and kidney development in mice lacking GDNF.
Nature
382:73-76[Medline].
-
Romeo G,
Ronchetto P,
Luo Y,
Barone V,
Seri M,
Ceccherini I,
Pasini B,
Bocciardi R,
Lerone M,
Käärläinen H,
Martucciello G
(1994)
Point mutations affecting the tyrosine kinase domain of the RET proto-oncogene in Hirschsprung's disease.
Nature
367:377-378[Medline].
-
Sanchez MP,
Silossantiago I,
Frisen J,
He B,
Lira SA,
Barbacid M
(1996)
Renal agenesis and the absence of enteric neurons in mice lacking GDNF.
Nature
382:70-73[Medline].
-
Sanicola M,
Hession C,
Worley D,
Carmillo P,
Ehrenfels C,
Walus L,
Robinson S,
Jaworski G,
Wei H,
Tizard R,
Whitty A,
Pepinsky R,
Cate R
(1997)
Glial cell line-derived neurotrophic factor-dependent RET activation can be mediated by two different cell-surface accessory proteins.
Proc Natl Acad Sci USA
94:6238-6243[Abstract/Free Full Text].
-
Schaar DG,
Sieber BA,
Dreyfus CF,
Black IB
(1993)
Regional and cell-specific expression of GDNF in rat brain.
Exp Neurol
124:368-371[Web of Science][Medline].
-
Strömberg I,
Björklund L,
Johansson M,
Tomac A,
Collins F,
Olson L,
Hoffer B,
Humpel C
(1993)
Glial cell line-derived neurotrophic factor (GDNF) is expressed in the developing but not adult striatum and stimulates developing dopamine neurons in vivo.
Exp Neurol
124:401-412[Web of Science][Medline].
-
Suhuchardt A,
D'Agati V,
Larsson-Blomberg L,
Constantini F,
Pachnis V
(1994)
Defects in the kidney and enteric nervous system of mice lacking the tyrosine kinase receptor Ret.
Nature
367:380-383[Medline].
-
Suvanto P,
Hiltunen J,
Arum'e U,
Moshnyakov M,
Sariola H,
Sainio K,
Saarma M
(1996)
Localization of glial cell line-derived neurotrophic factor (GDNF) mRNA in embryonic rat by in situ hybridization.
Eur J Neurosci
8:816-822[Web of Science][Medline].
-
Treanor J,
Goodman L,
Desauvage F,
Stone D,
Poulsen K,
Beck C,
Gray C,
Armanini M,
Pollock R,
Hefti F,
Phillips H,
Goddard A,
Moore M,
Buj-Bello A,
Davies A,
Asai N,
Takahashi M,
Vandlen R,
Henderson C,
Rosenthal A
(1996)
Characterization of a multicomponent receptor for GDNF.
Nature
382:80-83[Medline].
-
Trupp M,
Arenas E,
Fainzilber M,
Nilsson A-S,
Sieber B,
Grigoriou M,
Kilkenny C,
Salazar-Gueso E,
Pachnis V,
Arumäe U,
Sariola H,
Saarma M,
Ibáñez C
(1996)
Functional receptor for glial cell line-derived neurotrophic factor encoded by the c-ret proto-oncogene product.
Nature
381:785-789[Medline].
-
Trupp M,
Belluardo N,
Funakoshi H,
Ibáñez C
(1997)
Complementary and overlapping expression of glial cell line-derived neurotrophic factor (GDNF), c-ret proto-oncogene, and GDNF receptor-
indicates multiple mechanisms of trophic actions in the adult rat CNS.
J Neurosci
17:3554-3567[Abstract/Free Full Text]. -
Tsuzuki T,
Takahashi M,
Asai N,
Iwashita T,
Matsuyama M,
Asai J
(1995)
Spatial and temporal expression of the ret proto-oncogene product in embryonic, infant and adult rat tissues.
Oncogene
10:191-198[Web of Science][Medline].
-
Unsicker K
(1996)
GDNF: a cytokine at the interface of TGF-betas and neurotrophins.
Cell Tissue Res
286:175-178[Web of Science][Medline].
This article has been cited by other articles:

|
 |

|
 |
 
L. F. Yoong and H.-P. Too
Glial Cell Line-Derived Neurotrophic Factor and Neurturin Inhibit Neurite Outgrowth and Activate RhoA through GFR{alpha}2b, an Alternatively Spliced Isoform of GFR{alpha}2
J. Neurosci.,
May 23, 2007;
27(21):
5603 - 5614.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Johansson, I-H. Lee, L. Olson, and C. Spenger
Olfactory ensheathing glial co-grafts improve functional recovery in rats with 6-OHDA lesions
Brain,
December 1, 2005;
128(12):
2961 - 2976.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Jomary, R. M. Darrow, P. Wong, D. T. Organisciak, and S. E. Jones
Expression of Neurturin, Glial Cell Line-Derived Neurotrophic Factor, and Their Receptor Components in Light-Induced Retinal Degeneration
Invest. Ophthalmol. Vis. Sci.,
April 1, 2004;
45(4):
1240 - 1246.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Kholodilov, O. Yarygina, T. F. Oo, H. Zhang, D. Sulzer, W. Dauer, and R. E. Burke
Regulation of the Development of Mesencephalic Dopaminergic Systems by the Selective Expression of Glial Cell Line-Derived Neurotrophic Factor in Their Targets
J. Neurosci.,
March 24, 2004;
24(12):
3136 - 3146.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. T. Shepherd, J. Pietsch, S. Elworthy, R. N. Kelsh, and D. W. Raible
Roles for GFR{alpha}1 receptors in zebrafish enteric nervous system development
Development,
January 1, 2004;
131(1):
241 - 249.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. E. Redmond Jr.
Book Review: Cellular Replacement Therapy for Parkinson's Disease--Where We Are Today?
Neuroscientist,
October 1, 2002;
8(5):
457 - 488.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Harada, C. Harada, Y. Mitamura, C. Akazawa, K. Ohtsuka, S. Ohno, S. Takeuchi, and K. Wada
Neurotrophic Factor Receptors in Epiretinal Membranes After Human Diabetic Retinopathy
Diabetes Care,
June 1, 2002;
25(6):
1060 - 1065.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Japon, A. G. Urbano, C. Saez, D. I. Segura, A. L. Cerro, C. Dieguez, and C. V. Alvarez
Glial-Derived Neurotropic Factor and RET Gene Expression in Normal Human Anterior Pituitary Cell Types and in Pituitary Tumors
J. Clin. Endocrinol. Metab.,
April 1, 2002;
87(4):
1879 - 1884.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Tollet, A. W. Everett, and M. P. Sparrow
Development of Neural Tissue and Airway Smooth Muscle in Fetal Mouse Lung Explants . A Role for Glial-Derived Neurotrophic Factor in Lung Innervation
Am. J. Respir. Cell Mol. Biol.,
April 1, 2002;
26(4):
420 - 429.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C.-Y. Wang, F. Yang, X.-P. He, H.-S. Je, J.-Z. Zhou, K. Eckermann, D. Kawamura, L. Feng, L. Shen, and B. Lu
Regulation of Neuromuscular Synapse Development by Glial Cell Line-derived Neurotrophic Factor and Neurturin
J. Biol. Chem.,
March 15, 2002;
277(12):
10614 - 10625.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Andres, A. Forgie, S. Wyatt, Q. Chen, F. J. de Sauvage, and A. M. Davies
Multiple effects of artemin on sympathetic neurone generation, survival and growth
Development,
October 1, 2001;
128(19):
3685 - 3695.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Widenfalk, K. Lundstromer, M. Jubran, S. Brene, and L. Olson
Neurotrophic Factors and Receptors in the Immature and Adult Spinal Cord after Mechanical Injury or Kainic Acid
J. Neurosci.,
May 15, 2001;
21(10):
3457 - 3475.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Utsumi, H. Chiba, Y. Kamimura, M. Osanai, Y. Igarashi, H. Tobioka, M. Mori, and N. Sawada
Expression of GFRalpha -1, receptor for GDNF, in rat brain capillary during postnatal development of the BBB
Am J Physiol Cell Physiol,
August 1, 2000;
279(2):
C361 - C368.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Garces, G. Haase, M. S. Airaksinen, J. Livet, P. Filippi, and O. deLapeyriere
GFRalpha 1 Is Required for Development of Distinct Subpopulations of Motoneuron
J. Neurosci.,
July 1, 2000;
20(13):
4992 - 5000.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. V. Botchkareva, V. A. Botchkarev, P. Welker, M. Airaksinen, W. Roth, P. Suvanto, S. Muller-Rover, I. M. Hadshiew, C. Peters, and R. Paus
New Roles for Glial Cell Line-Derived Neurotrophic Factor and Neurturin : Involvement in Hair Cycle Control
Am. J. Pathol.,
March 1, 2000;
156(3):
1041 - 1053.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Worley, J. Pisano, E. Choi, L Walus, C. Hession, R. Cate, M Sanicola, and S. Birren
Developmental regulation of GDNF response and receptor expression in the enteric nervous system
Development,
January 10, 2000;
127(20):
4383 - 4393.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
E Doxakis, S Wyatt, and A. Davies
Depolarisation causes reciprocal changes in GFR(alpha)-1 and GFR(alpha)-2 receptor expression and shifts responsiveness to GDNF and neurturin in developing neurons
Development,
January 4, 2000;
127(7):
1477 - 1487.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Hashino, E. M. Johnson Jr, J. Milbrandt, M. Shero, R. J. Salvi, and C. S. Cohan
Multiple Actions of Neurturin Correlate with Spatiotemporal Patterns of Ret Expression in Developing Chick Cranial Ganglion Neurons
J. Neurosci.,
October 1, 1999;
19(19):
8476 - 8486.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. J. Collier, C. E. Sortwell, and B. F. Daley
Diminished Viability, Growth, and Behavioral Efficacy of Fetal Dopamine Neuron Grafts in Aging Rats with Long-Term Dopamine Depletion: An Argument for Neurotrophic Supplementation
J. Neurosci.,
July 1, 1999;
19(13):
5563 - 5573.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Krieglstein, P. Henheik, L. Farkas, J. Jaszai, D. Galter, K. Krohn, and K. Unsicker
Glial Cell Line-Derived Neurotrophic Factor Requires Transforming Growth Factor-beta for Exerting Its Full Neurotrophic Potential on Peripheral and CNS Neurons
J. Neurosci.,
December 1, 1998;
18(23):
9822 - 9834.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. R Ribchester, D. Thomson, L. J Haddow, and Y. A Ushkaryov
Enhancement of spontaneous transmitter release at neonatal mouse neuromuscular junctions by the glial cell line-derived neurotrophic factor (GDNF)
J. Physiol.,
November 1, 1998;
512(3):
635 - 641.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. A. Horger, M. C. Nishimura, M. P. Armanini, L.-C. Wang, K. T. Poulsen, C. Rosenblad, D. Kirik, B. Moffat, L. Simmons, E. Johnson Jr, et al.
Neurturin Exerts Potent Actions on Survival and Function of Midbrain Dopaminergic Neurons
J. Neurosci.,
July 1, 1998;
18(13):
4929 - 4937.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Yu, S. Scully, Y. Yu, G. M. Fox, S. Jing, and R. Zhou
Expression of GDNF Family Receptor Components during Development: Implications in the Mechanisms of Interaction
J. Neurosci.,
June 15, 1998;
18(12):
4684 - 4696.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|

|